Skip to main content
OpenTrials

Clinical trial condition

Coagulation Protein Disorders

Explore clinical trials studying Coagulation Protein Disorders. Study availability and eligibility vary by location and protocol.

24 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Coagulation Protein Disorders trial results

Completed

Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients (BMN 270-301)

NCT03370913

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +9 more
Locations
  • Los Angeles Orthopedic Hospital, Orthopedic Hemophilia Treatment Center Los Angeles, California, United States
  • UC Davis Hemophilia Treatment Center Sacramento, California, United States
  • University of California San Diego, Hematology and Oncology, Hemophilia &Thrombosis Treatment Center San Diego, California, United States
  • UCSF Medical Center San Francisco, California, United States
View all 49 locations
View Trial Details
Completed

A Gene Transfer Study for Hemophilia A

NCT03003533

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • University of California Davis - Hemostasis and Thrombosis Center Sacramento, California, United States
  • University of Florida Health Gainesville, Florida, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Mississippi Center for Advanced Medicine Madison, Mississippi, United States
View all 16 locations
View Trial Details
Completed

Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products

NCT02976753

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Swedish Orphan Biovitrum Research site Innsbruck, Austria
  • Swedish Orphan Biovitrum Research site Linz, Austria
  • Swedish Orphan Biovitrum Research Site Sankt Pölten, Austria
  • Swedish Orphan Biovitrum Research site Vienna, Austria
View all 36 locations
View Trial Details
Completed

A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B

NCT03055611

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • Swedish Orphan Biovitrum Reserach site Berlin, Germany
  • Swedish Orphan Biovitrum Reserach Site Blaubeuren Abbey, Germany
  • Swedish Orphan Biovitrum Research Site Bonn, Germany
  • Swedish Orphan Biovitrum Research Site Delmenhorst, Germany
View all 22 locations
View Trial Details
Completed

A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France

NCT03655340

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Swedish Orphan Biovitrum Research Site (CHU de Bordeaux) Bordeaux, France
  • Swedish Orphan Biovitrum Research Site Brest, France
  • Swedish Orphan Biovitrum Research Site Caen, France
  • Swedish Orphan Biovitrum Research Site Chambéry, France
View all 18 locations
View Trial Details
Completed

Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B

NCT03276130

Conditions
Anxiety Disorders, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +16 more
Locations
  • Swedish Orphan Biovitrum Research Site Copenhagen, Denmark
  • Swedish Orphan Biovitrum Research Site Helsinki, Finland
  • Swedish Orphan Biovitrum Research Site Gothenburg, Sweden
  • Swedish Orphan Biovitrum Research Site Malmö, Sweden
View Trial Details
Completed

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

NCT03734588

Conditions
Adeno-Associated Virus (AAV), Blood Coagulation Disorder, Blood Coagulation Disorders, +18 more
Locations
  • Orthopaedic Institute for Children Los Angeles, California, United States
  • Illinois Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Mississippi Center for Advanced Medicine Madison, Mississippi, United States
View Trial Details
Completed

Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

NCT03876301

Conditions
Blood Coagulation Disorder, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +9 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • University of Florida Gainesville, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Children's Hospital of Michigan Detroit, Michigan, United States
View Trial Details
Completed

A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

NCT03417245

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Investigational Site Number 0140 Little Rock, Arkansas, United States
  • Investigational Site Number 128 Gainesville, Florida, United States
  • Investigational Site Number 103 Tampa, Florida, United States
  • Investigational Site Number 102 Chicago, Illinois, United States
View all 64 locations
View Trial Details

Related conditions